Perrigo Company - PRGO Net Assets per Single Share

Graphic logo of Perrigo Company plc (PRGO)

Perrigo Company plc (PRGO) operates under intense pricing pressure, countering the expansion of budget generics and retail store brands. Simultaneously, Perrigo Company plc (PRGO) capitalizes on the growing demand for affordable alternatives to brand-name products by expanding its pool of retail counterparties. The current figure stands at 18.29. This price action chart on GURU.Markets complements data regarding a diversified network of plants across Europe and the US, which guarantees uninterrupted supplies.

Perrigo Company PLC (PRGO): Share Book Value from 07/04/2022 to 10/27/2026
Manufactured products of Perrigo

Investors use this indicator to assess the real value of a shareholder's stake in the business. The metric is calculated as the difference between all assets and liabilities, divided by the number of shares. For Perrigo Company plc (PRGO), the stability of this value confirms resilience to geopolitics, despite risks associated with Asian raw material supplies. A decline in asset turnover here signals potential foregone profits. By analyzing the book value per share chart, one can evaluate the fundamental strength of the company.

Competitors of Perrigo Company plc (PRGO)

Book Value per Share HLN|KVUE: Book Value of One Share|Net Assets per Single Share VRNA|MENS (jyongbio.com) - Net Asset Value per Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Alvotech Corp (ALVO) - Book Value per Share|Accounting Value of a Share Liquidia Inc. (LQDA)|Book Value per Share GLPG (Galapagos NV)|anipharmaceuticals.com - Book Value per Share|Net Assets per Single Share MannKind (MNKD)|AMPH: Accounting Value of a Share|PCRX (Pacira) - Net Assets per Single Share|ARS Corp (SPRY) - Accounting Value per Share|TBPH (Theravance Biopharma) - Book Value per Share|Book Value per Share aquestive.com (AQST)|scPharmaceuticals Inc. (SCPH) - Accounting Value per Share|Accounting Value of a Share TECX (tectonictx.com)|TNXP: Net Assets per Single Share|SXTC - Net Asset Value per Share|Accounting Value per Share Eupraxia Pharma EPRX|BHST - Book Price of a Share|Book Value per Share eXoZymes EXOZ|Oramed Pharmaceuticals Inc. (ORMP) - Accounting Value of a Share|Book Value per Share ENTX (Entera Bio Ltd)|Net Asset Value per Share HYFT|ABVC BioPharma (ABVC) - Net Assets per Single Share|Accounting Value of a Share CPIX (cumberlandpharma.com)|Quantum BioPharma (QNTM) - Net Assets per Single Share|Share Book Value FibroGen Inc FGEN|TELO (Telomir Pharma) - Book Value per Share|RANI: Net Asset Value per Share|Net Assets per Single Share synergychc.com SNYR|RLYB (Rallybio) - Accounting Value of a Share|LEXX - Net Assets per Single Share|Accounting Value of a Share Pulmatrix Inc|PTHL (Pheton Holdings Ltd) - Book Value per Share|Net Assets per Share aptorumgroup.com (APM)|LYRA (Lyra Therapeutics, Inc.) - Book Value per Share|Impact BioMedical, Inc. - Book Value of One Share|TNFA (TNF Pharma) - Net Assets per Single Share|cbdMD, Inc. (YCBD) - Net Asset Value per Share|Accounting Value per Share PainReform Limited PRFX|Altamira Therapeutics Ltd. (CYTO) - Accounting Value of a Share|Book Value per Share LIPO|Accounting Value per Share OPTN|Pieris Pharmaceuticals, Inc. - Net Assets per Single Share|Net Asset Value per Share PROC (Procaps Group)|Petros - Net Assets per Single Share|Qilian International Corp - Accounting Value per Share|Net Assets per Single Share Acelyrin, Inc.|TFFP - Share Book Value